Recombinant Vaccine

This page contains recent news articles, when available, and an overview of Recombinant Vaccine but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Recombinant Vaccine

Genital warts: not just a skin infection help protect yourself  -  22 Nov 2009
Philippine StarOne can also help protect oneself through vaccination with the quadrivalent HPV recombinant vaccine. Erstwhile indicated only for girls and women age 9-45 ...

FDA Expert Panel Declines to Endorse New Influenza Vaccine  -  ‎Nov 20, 2009‎
MedscapeOne phase 3 study, in young healthy adults aged 18 to 49 years, found that the protective efficacy of the recombinant vaccine was 44.8%. ...

Warts off now!  -  ‎Nov 16, 2009‎
Manila BulletinGardasil is a quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine. It has demonstrated cervical cancer protection with demonstrated ...

Medicago to present at the U.S. Department of Health and Human Services ...  -  ‎Nov 4, 2009‎
ReutersMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine ...

Crucell Announces Third Quarter 2009 Results  -  ‎Nov 4, 2009‎
CNNMoney.com (press release)Hepavax-Gene®: Recombinant vaccine against hepatitis B. * Epaxal® Junior: Paediatric dose (0.25mL) of Epaxal®, the only aluminum-free vaccine against ...

Medicago announces filing of preliminary short form prospectus  -  ‎Nov 12, 2009‎
Canada NewsWire (press release)Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine ...

Forum discusses dangers of rabies  -  ‎Nov 9, 2009‎
The Daily BeaconRaboral VR-G is an oral recombinant vaccine that researchers give to raccoons. The team makes them fish and dog-flavored bait to attract the animals. ...

Medicago announces $10080000 bought deal equity financing  -  ‎Nov 6, 2009‎
CNW Telbec (Communiqué de presse)Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine ...

High Growth Forecasted for the China Vaccine Market Report, 2007-2009  -  Dec 11, 2008
MarketWatchSize 3.2.3 Main Products 3.2.3.1 Plasma Derived HB Vaccine 3.2.3.2 Recombinant HB Vaccine 3.2.3.3 Recombinant Vaccine of HB Virus Surface Antigens(CHO

Daiichi Sankyo forms alliance with The Kitasato Institute  -  Dec 26, 2008
Trading Markets (press release),Daiichi Sankyo has shown interest in The Kitasato Institute and its next generation recombinant vaccine technology that uses the internationally-respected

The Scientist Ending Malaria with His Army of Mosquitoes  -  Dec 8, 2008
EsquireOnce they had created a "recombinant" vaccine they liked, they shot it into their bodies, then used the can and the mesh and the cloth to give themselves a

Medicago announces expansion of manufacturing facility  -  Dec 15, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Half a Flu Shot May Work in a Pinch  -  Dec 8, 2008
MedPage Today,..."Cell culture and recombinant vaccine-based production are needed, and the time has come to relegate the use of eggs back to the kitchen where they belong,"

Allergic Reactions Uncommon with Cervical Cancer Vaccine  -  Dec 9, 2008
Cancer Consultants,Allergic reactions to Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) are uncommon and most young women who have a

Hepatitis C drug doses ineffective  -  Dec 9, 2008
Belleville News Democrat,However, research will continue with a similar recombinant vaccine that is expected to be even more potent without the potentially dangerous gene.

VIVALIS SECURES IMPORTANT PATENTS  -  Dec 10, 2008
Euronext (persbericht),Nantes (France) - December 10th, 2008 - Vivalis (NYSE Euronext: VLS) announced today that it has been granted two major patents by the United States and

HPV Vaccine Effective in Males  -  Nov 17, 2008
Cancer Consultants,Researchers from the H. Lee Moffitt Cancer Center have reported that Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine)

Novel TB Vaccine May Be Safer for HIV-Infected Patients  -  Oct 24, 2008
MedPage Today,In guinea pigs, the recombinant vaccine provided better protection against tuberculosis than the Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine

Crucell Announces Third Quarter 2008 Results  -  Nov 10, 2008
MarketWatchHepavax-Gene(R): Recombinant vaccine against hepatitis B. * Epaxal(R) Junior: Paediatric dose (0.25mL) of Epaxal(R) - the only aluminum-free vaccine for

Medicago Shareholders Approve $15975000 Investment by Philip ...  -  Nov 10, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Demand for cervical cancer vaccine soars, docs say  -  Nov 5, 2008
The Zonie Report,It is a recombinant vaccine that takes a small portion of the HPV virus and combines it with other solutions to change its form, Agenbroad says.

Don't drink if you are pregnant  -  Nov 4, 2008
Belleville News Democrat,However, research will continue with a similar recombinant vaccine that is expected to be even more potent without the potentially dangerous gene.

Wednesday in Havana: Foreign Experts Will Attend Seminar on Innovation  -  Nov 4, 2008
Cuba Headlines,...where the Hepatitis B recombinant vaccine Heberbiovac HB, which is registered and commercialized in dozens of countries, was produced.

Преп?т?тви? на пути ?оздани? вакцины против ВИЧ-1  -  Oct 24, 2008
Коммерче?ка? биотехнологи?,A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J. Immunol. 170, 1416–1422 (2003). 89. Liu, J. et al. Magnitude and phenotype of

$15975000 Investment by Philip Morris International in Medicago  -  Sep 22, 2008
MarketWatchMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Gardasil Approval Expanded to Prevention of HPV-Related Vulvar ...  -  Sep 18, 2008
Medscape (subscription)11, 16, and 18] recombinant vaccine) has been expanded to include the indication of preventing vaginal and vulvar cancer caused by human papillomavirus

Vietnam approves cervical vaccine  -  Sep 22, 2008
Thanh Nien Daily,Gardasil, produced by Merk & Co., Inc., is a recombinant vaccine for preventing cancer in girls and women aged over 10 who contract certain types of the

The Gynecologic Oncology Group: Advancing The Prevention And The ...  -  Sep 16, 2008
Cancer Consultants,The HPV vaccine that is currently on the market is Gardasil® (Quadrivalent Human Papillomavirus Recombinant Vaccine), which targets HPV types 6 and 11

Gardasil® Approved for Prevention of Vaginal and Vulvar Cancers  -  Sep 15, 2008
Cancer Consultants,18] Recombinant Vaccine) for the prevention of cancers of the vagina and vulva. Human papillomaviruses (HPV) consist of more than 100 different viruses.

Medicago completes $2210000 non-brokered private placement  -  Aug 29, 2008
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Medicago announces 2008 second quarter results  -  Aug 28, 2008
Stockhouse,Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

UPDATE 1-Merck vaccine wins US OK for vaginal cancer  -  Sep 12, 2008
Hemscott,The genetically engineered, or recombinant, vaccine is effective against four strains of the human papilloma virus, which is passed through sexual contact

Medicago Receives Contribution From NRC-IRAP for Seasonal Flu ...  -  Jul 3, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Medicago's H5N1 VLP vaccine demonstrates cross-reactivity against ...  -  Jun 25, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Taking a Shot at Cervical Cancer  -  Jul 7, 2008
Cancer Consultants,Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine)—the HPV vaccine currently available in the United States—also

Ghana: Eradicating Malaria And the Search for New Tools  -  Jul 3, 2008
AllAfrica.com,...to generate P. falciparum sporozoites, screening of DNA library with monocional antibody and puling out gene, sequence, peptide recombinant vaccine.

Patent granted for ProBioGen's avian cell line AGE1.CR  -  Jul 10, 2008
PharmaLive.com (press release),MVA is among the most promising vectors intended as recombinant vaccine against chronic infectious diseases such as AIDS, tuberculosis and malaria.

Gennova Biopharmaceuticals collaborates with PATH MVI  -  Jun 17, 2008
Moneycontrol.com (press release),Gennova Biopharmaceuticals Ltd (GBL) is collaborating with the PATH Malaria Vaccine Initiative (MVI) to create a dedicated malaria vaccine manufacturing

Medicago to present at the 2008 BIO International Convention in ...  -  Jun 16, 2008
Trading Markets (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Childers receives research in Oral Biology Award  -  Jun 25, 2008
EurekAlert (press release),With more than 50 publications, Dr. Childers currently supervises a large project in Liposomal Recombinant Vaccine and Caries Immunity, and another project

Medicago Announces 2008 First Quarter Results  -  28 May 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Anthrax Vaccine Loses to Lobbying  -  May 19, 2008
The Washington Independent,...“I’m glad that someone picked up our recombinant vaccine,? he said. “From my perspective, it’sa good product. I’m hopeful that the huge investment and time

Crucell Announces First Quarter 2008 Results  -  May 12, 2008
CNNMoney.comIn April, Crucell announced that the novel recombinant vaccine (using adenovirus serotype 26 (rAd26) vector), which is jointly developed with the Beth

Expressing hepatitis B virus surface  -  May 19, 2008
Checkbiotech.org (press release),The infection is preventable by vaccination, and after the development of a commercial recombinant vaccine derived from yeast, there was a decline in the

Medicago announces poster presentation at the IDSA Seasonal and ...  -  May 16, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Novartis Menveo(R) Vaccine Shows Superior Immune Response Against ...  -  May 6, 2008
FOXBusinessNovartis is also developing a recombinant vaccine to provide broad coverage against multiple strains of serogroup B, for which no vaccine is currently

Medicago Appoints New VP Manufacturing  -  May 7, 2008
FOXBusinessMedicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Emergent BioSolutions to purchase Protein Sciences' Phase III ...  -  May 26, 2008
RTT News,...(RTTNews) - Tuesday, biopharmaceutical Company Emergent BioSolutions Inc. (EBS: News, Chart, Quote ) and Protein Sciences Corporation or PSC said that the

Medicago and Investissement Québec agree to a decrease in interest ...  -  Apr 29, 2008
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Syncope After Vaccination --- United States, January 2005--July 2007  -  May 1, 2008
Trading Markets (press release),...recommended use of three newly licensed vaccines for adolescents*: the quadrivalent human papillomavirus recombinant vaccine (HPV) (Gardasil[Note (R)],

Diagnosis and Treatment of Lyme Disease  -  May 3, 2008
RedOrbit,A recombinant vaccine, LYMErix (SmithKline Beecham Biologicals, Philadelphia, PA), directed toward a B burgdorferi surface protein (lipoprotein

Market Report -- In Play (EBS)  -  May 26, 2008
MSN MoneyEmergent BioSolutions to acquire Protein Sciences' Ph. III recombinant flu vaccine candidate; FluBlok, and related novel platform technology Co and Protein

PharmAthene Reports First Quarter 2008 Financial Results  -  May 14, 2008
PharmaLive.com (press release),ANNAPOLIS, Md., May 13, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc. a biodefense company developing medical countermeasures against biological and

Speaking of Women's Health Gives the Gift of Knowledge and Good ...  -  May 1, 2008
PR Newswire (press release),Kellogg's Snacks, Gardasil [Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine], Slim-Fast, Promise Activ, Vaseline Intensive Care,

New technology for boosting vaccine efficiency  -  Apr 24, 2008
EurekAlert (press release),This is called a recombinant vaccine. Recombinant vaccines give the most hope today as anti-viral and anti-cancer vaccines. They train the immune system to

Research boosts tuberculosis vaccine  -  Apr 7, 2008
ScienceAlert,One approach to improving the effectiveness of BCG given to infants is to boost its effect in adolescence or adulthood with a non-viable recombinant vaccine

Crucell Announces First in Man Study with New Adenovirus Vector  -  Apr 3, 2008
CNNMoney.comThe AdVac® technology is specifically designed to manage the problem of pre-existing immunity in humans against the most commonly used recombinant vaccine

Medicago appoints new Chief Financial Officer  -  Apr 21, 2008
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Cancer vaccine launched in SA  -  Apr 7, 2008
Sowetan,Gardasil, branded as quadrivalent human papillomavirus (HPV) recombinant vaccine, is aimed at protecting women and girls as young as nine against diseases

Merck Reports First-Quarter 2008 Financial Results  -  Apr 21, 2008
Business Wire (press release),Worldwide sales of the Company's cervical cancer vaccine GARDASIL (Human Papillomavirus (HPV) Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine) as

Medicago signs second licensing agreement with Fortune 100 Company  -  Feb 7, 2008
Canada NewsWire (press release),Medicago is developing VLP vaccines to protect against H5N1 pandemic influenza, using a transient expression system which produces recombinant vaccine

Camote beats dengue fever  -  Jan 28, 2008
Sun.Star,Research is also being conducted to develop second-generation recombinant vaccine viruses. "Therefore, an effective dengue vaccine for public use will not

The OIE expands its action in biotechnologies in anticipation of ...  -  Jan 31, 2008
OIE (press release),Aujeszky's disease (pseudorabies) is also under control in many parts of the Americas and Europe mainly thanks to a recombinant vaccine.



Background information on Recombinant Vaccine [When available]

[an error occurred while processing this directive]

Search the web for more resources on Recombinant Vaccine



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy